Am J Transplant, Volume 22, Suppl 3 Archives - Page 47 of 190 - ATC Abstracts

2022 American Transplant Congress
Cost-Effectiveness of an Intra-Operative Renal Allograft Cooling Device
K. Hansen¹, C. Yock², J. Pietzsch²
¹University of California, San Francisco, San Francisco, CA, ²Stanford, Palo Alto, CA
*Purpose: Existing literature shows intra-operative cooling of a renal allograft during anastomosis reduces the incidence of delayed graft function in deceased donor kidney transplant recipients…
2022 American Transplant Congress
Letermovir for Prophylaxis of Cytomegalovirus After Solid Organ Transplantation: A Single-Center, Observational Study
T. N. Bullard¹, C. A. Moore², J. Dasigi², L. M. Sacha², C. A. Iasella³, K. A. Shimko², E. K. McCreary⁴, F. P. Silveira⁴
¹Massachusetts General Hospital, Boston, MA, ²UPMC, Pittsburgh, PA, ³Univ of Pittsburgh, Pittsburgh, PA, ⁴Univ of Pittsburgh and UPMC, Pittsburgh, PA
*Purpose: Cytomegalovirus (CMV) infections cause significant complications post-transplant; however, prophylactic medications are often limited by toxicities. Letermovir is a novel terminase inhibitor specific to CMV…
2022 American Transplant Congress
Low Fixed Tacrolimus Starting Dose and the Correlation with Renal Allograft Rejection
R. Davoudi, E. Kitchel, S. Lee, T. Tan, T. Sievers, S. Bunnapradist
David Geffen School of Medicine, Los Angeles, CA
*Purpose: Achieving a tacrolimus therapeutic trough concentration (C0) by post-operative day (POD) 3-7 has been associated with a reduced risk for rejection. Although FDA prescribing…
2022 American Transplant Congress
Evaluation of Renal Function After Donation in Living Marginal Kidney Donor
S. Harada¹, H. Sasaki², Y. Takada², D. Takamoto², T. Hirano², T. Kan¹, Y. Yamagata¹, H. Harada², K. Minami¹, K. Moriya¹, H. Tanaka¹
¹Urology, Sapporo City General Hospital, Sapporo, Japan, ²Kidney Transplant Surgery, Sapporo City General Hospital, Sapporo, Japan
*Purpose: Chronic kidney-donor shortage is major concern in Japan where more than 90% of recipients received kidneys from living donor as kidney transplantation from deceased…
2022 American Transplant Congress
Discovery of Risk Factor Control Targets Using Machine Learning and Network Analysis for One-Year Renal Allograft Dysfunction
Y. Lee¹, M. Hong², J. Kong³, O. Kwon⁴, C. Jung⁵, J. Yang⁶, M. Kim⁷, H. Han⁸, S. Nam⁹
¹Division of Nephrology, Department of Internal medicine, CHA Bundang Medical Center, Seongnam, Korea, Republic of, ²Department of Biomedical Informatics,, CHA University School of Medicine, Seongnam, Korea, Republic of, ³Department of Nephrology,, BHS Hanseo Hospital, Pusan, Korea, Republic of, ⁴Department of Surgery, College of Medicine, Han Yang University, Seoul, Korea, Republic of, ⁵Department of Surgery, Korea University Anam Hospital, Seoul, Korea, Republic of, ⁶Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of, ⁷Department of Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of, ⁸Department of Biomedical Informatics, CHA University School of Medicine, CHA University, Seongnam, Korea, Republic of, ⁹Department of Ophthalmology, CHA Bundang Medical Center, Seongnam, Korea, Republic of
*Purpose: Early identification of graft loss risk and timely therapeutic intervention are crucial for preventing late renal allograft failure and improving long-term graft function. This…
2022 American Transplant Congress
Humoral and Cellular Immunity 6 Months After SARS-CoV-2 Infection in Solid-Organ Transplant Recipients
S. Morris¹, S. Courel², S. Pallikkuth³, S. Pahwa³, A. Fernandez⁴, S. Anjan¹, G. Guerra⁵, M. Alcaide¹, Y. Natori¹
¹Division of Infectious Disease, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, ²University of Miami Miller School of Medicine, Miami, FL, ³Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, ⁴Infectious Disease Associates of Tampa Bay, Tampa Bay, FL, ⁵University of Miami Jackson Memorial Hospital, Miami, FL
*Purpose: The purpose of this study was to evaluate long term humoral and cellular immunity generated following SARS-CoV-2 infection in solid organ transplant recipients (SOTR).*Methods:…
2022 American Transplant Congress
Development of Diagnostic Algorithms for Peri-Operative Error Cause and Effect Analysis in Renal Transplant Surgery
P. Gogalniceanu¹, H. Maple¹, G. Papadakis¹, P. Chandak¹, I. Loukopoulos¹, J. Olsburgh¹, N. Kessaris¹, F. Calder¹, N. Sevdalis², N. Mamode¹
¹Guy's and St.Thomas' NHS Foundation Trust, London, United Kingdom, ²King's College London, London, United Kingdom
*Purpose: Peri-operative safety metadata in transplant surgery remain limited. Lack of standardisation and limited models of failure analysis, as well as non-intuitive error taxonomies, deter…
2022 American Transplant Congress
Living Donor Liver Transplantation: A Better Option for Patients 70 Years or Older
A. Ganoza, A. Duarte-Rojo, V. Gunabushanam, M. Molinari, S. Ganesh, D. Reddy, A. M. Thompson, A. Tevar, C. Hughes, A. Humar
University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: The burden of liver diseases in patients of advanced age has risen. Irrespective of its possible causes, older recipients have a higher waitlist mortality…
2022 American Transplant Congress
Kidney Transplantation in Mentally Challenged Patients; a Single Center Experience
J. Yagan¹, T. S. Mahmoud¹, O. Gheith¹, P. Nair¹, T. Alotaibi²
¹Nephrology, Hamed Al-Essa Organ Transplant Center, Kuwait, Kuwait, ²Pathology, Hamed Al-Essa Organ Transplant Center, Kuwait, Kuwait
*Purpose: Kidney transplant is the best choice of treatment for patients with end stage kidney disease. There are medical conditions that may pose an ethical…
2022 American Transplant Congress
Myeloid Molecular Signature of Ischemia-Reperfusion Injury in Human Liver Transplantation
R. A. Sosa¹, R. Ahn², A. Terry¹, Z. Qian², F. Li¹, S. Sen¹, T. Ito³, B. V. Naini¹, F. Kaldas³, A. Hoffmann², R. W. Busuttil³, D. W. Gjertson¹, J. Kupiec-Weglinski³, E. F. Reed¹
¹Pathology and Lab Medicine, UCLA, Los Angeles, CA, ²Microbiology, Immunology and Molecular Genetics, UCLA, Los Angeles, CA, ³Surgery, UCLA, Los Angeles, CA
*Purpose: Ischemia reperfusion injury (IRI) is well-appreciated as a significant clinical concern for recipients of liver transplantation, yet there are still no diagnostic or therapeutic…